Risk analysis and an alternative protocol for reduction of screening for retinopathy of prematurity

Journal of AAPOS

Volumn 13, Issue 6, 2009, Pages 539-545

  Yang, Michael B ^a   Donovan, Edward F ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIRTH; BIRTH WEIGHT; CALCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; EYE; EYE EXAMINATION; FEMALE; GENDER; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; PREMATURITY; PRIORITY JOURNAL; RACE; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING; SIMULATION; VALIDATION STUDY;

BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; VISION SCREENING;

EID: 71649113094     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaapos.2009.10.002     Document Type: Article

References (35)

1. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: Three-month outcome. Arch Ophthalmol 108 (1990) 195-204
2. Palmer E.A., Hardy R.J., Dobson V., Phelps D.L., Quinn G.E., Summers C.G., and Cryotherapy for Retinopathy of Prematurity Cooperative Group. 15-year outcomes following threshold retinopathy of prematurity: Final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 123 (2005) 311-318
3. Early Treatment of Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: Results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121 (2003) 1684-1696
4. Palmer E.A., Flynn J.T., Hardy R.J., Phelps D.L., Phillips C.L., Schaffer D.B., and Cryotherapy for Retinopathy of Prematurity Cooperative Group. Incidence and early course of retinopathy of prematurity. Ophthalmology 98 (1991) 1628-1640
5. Saunders R.A., and Hutchinson A.K. The future of screening for retinopathy of prematurity. J AAPOS 6 (2002) 61-63
6. Section on Ophthalmology: American Academy of Pediatrics, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 117 (2006) 572-576
7. Reynolds J.D., Dobson V., Quinn G.E., Fielder A.R., Palmer E.A., Saunders R.A., and CRYO-ROP and LIGHT-ROP Cooperative Groups. Evidence-based screening criteria for retinopathy of prematurity: Natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol 120 (2002) 1470-1476
8. Palmer E.A. How safe are ocular drugs in pediatrics?. Ophthalmology 93 (1986) 1038-1040
9. Laws D.E., Morton C., Weindling M., and Clark D. Systemic effects of screening for retinopathy of prematurity. Br J Ophthalmol 80 (1996) 425-428
10. Belda S., Pallas C.R., De la Cruz J., and Tejada P. Screening for retinopathy of prematurity: Is it painful?. Biol Neonate 86 (2004) 195-200
11. Rush R., Rush S., Nicolau J., Chapman K., and Naqvi M. Systemic manifestations in response to mydriasis and physical examination during screening for retinopathy of prematurity. Retina 24 (2004) 242-245
12. Wood M.G., and Kaufman L.M. Apnea and bradycardia in two premature infants during routine outpatient retinopathy of prematurity screening. J AAPOS 13 (2009) 501-503
13. Quinn G.E., and Evans J. Improving safety for babies during the outpatient retinopathy of prematurity examination. J AAPOS 13 (2009) 429
14. Wright K., Anderson M.E., Walker E., and Lorch V. Should fewer infants be screened for retinopathy of prematurity in the managed care era?. Pediatrics 102 (1998) 31-34
15. Lee S.K., Normand C., McMillan D., Ohlsson A., Vincer M., and Lyons C. Canadian Neonatal Network. Evidence for changing guidelines for routine screening for retinopathy of prematurity. Arch Pediatr Adolesc Med 155 (2001) 387-395
16. Goble R.R., Jones H.S., and Fielder A.R. Are we screening too many babies for retinopathy of prematurity?. Eye 11 (1997) 509-514
17. Brennan R., Gnanaraj L., and Cottrell D.G. Retinopathy of prematurity in practice. I: Screening for threshold disease. Eye 17 (2003) 183-188
18. Javitt J., Dei Cas R., and Chiang Y.P. Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity. Pediatrics 91 (1993) 859-866
19. Schalij-Delfos N.E., Zijlmans B.L.M., and Cats B.P. Towards a universal approach for screening of retinopathy of prematurity (ROP). Doc Ophthalmol 92 (1996) 137-144
20. Termote J.U., Donders A.R., Schalij-Delfos N.E., Lenselink C.H., Derkzen van Angeren C.S., and Lissone S.C. Can screening for retinopathy of prematurity be reduced?. Biol Neonate 88 (2005) 92-97
21. Schaffer D.B., Palmer E.A., Plotsky D.F., Metz H.S., Flynn J.T., and Tung B. Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology 100 (1993) 230-237
22. Yang M.B., Donovan E.F., and Wagge J.R. Race, gender, and clinical risk index for babies (CRIB) score as predictors of severe retinopathy of prematurity. J AAPOS 10 (2006) 253-261
23. Glynn R.J., and Rosner B. Accounting for the correlation between fellow eyes. Arch Ophthalmol 110 (1992) 381-387
24. Section on Ophthalmology: American Academy of Pediatrics, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 100 (1997) 273-274
25. Section on Ophthalmology: American Academy of Pediatrics, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 108 (2001) 809-811
26. Ober R.R., Palmer E.A., Drack A.V., and Wright K.W. Retinopathy of prematurity. In: Wright K.W., and Spiegel P.H. (Eds). Pediatric ophthalmology and strabismus (2003), Springer-Verlag, New York, NY 615
27. Rosner B. Statistical methods in ophthalmology: An adjustment for the intraclass correlation between eyes. Biometrics 38 (1982) 105-114
28. Averbukh E. The evidence supporting the early treatment for type 1 retinopathy of prematurity needs further evaluation. Arch Ophthalmol 123 (2005) 406
29. Coats D., and Saunders R. The dilemma of exercising clinical judgment in the treatment of retinopathy of prematurity. Arch Ophthalmol 123 (2005) 408-409
30. Vander J.F., MacNamara J.A., Tasman W., and Brown G.C. Revised indications for early treatment of retinopathy of prematurity. Arch Ophthalmol 123 (2005) 406-407
31. Good W.V., and Hardy R.J. Reply to letters concerning ETROP. Arch Ophthalmol 123 (2005) 409-410
32. International Committee for the Classification of Retinopathy of Prematurity. The International classification of retinopathy of prematurity revisited. Arch Ophthalmol 124 (2005) 1669-1670
33. The International Neonatal Network. The CRIB (clinical risk index for babies) score: A tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet 342 (1993) 193-198
34. Lofqvist C., Andersson E., Sigurdsson J., Engstrom E., Hard A.L., and Niklasson A. Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity [published erratum in: Arch Ophthalmol. 2007;125:426]. Arch Ophthalmol 124 (2006) 1711-1718
35. Gilbert C., Fielder A., Gordillo L., Quinn G., Semiglia R., Visintin P., and International NO-ROP Group. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: Implications for screening programs. Pediatrics 115 (2005) e518-e525